As of December 2024, GeneOne Life Science has a market cap of $108.00M. This makes GeneOne Life Science the world's 19715th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $142.38M | -7.39% |
2023 | $153.75M | -60.22% |
2022 | $386.54M | -55.93% |
2021 | $877.02M | 16.96% |
2020 | $749.84M | 878.87% |
2019 | $76.60M | -37.21% |
2018 | $122.00M | -26.57% |
2017 | $166.13M | -45.22% |
2016 | $303.25M | 9.81% |
2015 | $276.15M | 29.70% |
2014 | $212.92M | 43.63% |
2013 | $148.24M | -10.07% |
2012 | $164.84M | - |